Azzad Asset Management Inc /Adv Supernus Pharmaceuticals, Inc. Transaction History
Azzad Asset Management Inc /Adv
- $848 Billion
- Q2 2024
A detailed history of Azzad Asset Management Inc /Adv transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 15,737 shares of SUPN stock, worth $541,038. This represents 0.05% of its overall portfolio holdings.
Number of Shares
15,737
Previous 15,697
0.25%
Holding current value
$541,038
Previous $535 Million
21.38%
% of portfolio
0.05%
Previous 0.06%
Shares
14 transactions
Others Institutions Holding SUPN
# of Institutions
255Shares Held
59.2MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$357 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$211 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$181 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$98.6 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$92.1 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.84B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...